摘要:
Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
摘要:
Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
摘要翻译:提供了结合ICAM-1的人源化抗体。 抗体包括选自:SEQ ID NO:1和3(HumA)的那些; SEQ ID NO:5和7(HumB); SEQ ID NO:9和11(HumC); SEQ ID NO:13和15(HumD); SEQ ID NO:17和19(HumE); SEQ ID NO:21和23(HumF); SEQ ID NO:25和27(HumG); SEQ ID NO:29和31(HumH); 和SEQ ID NO:33和35(HumI)。 还提供了能够结合ICAM-1表位的人源化抗体的子序列。 还提供了使用能够结合ICAM-1表位的人源化抗体抑制细胞病原体感染(例如HRV)的方法。
摘要:
Fused pyradazine derivatives which are usefule as CDK inhibitors are described herein. The described invention alos includes methods of making such fused pyradazine derivatives as wells as methods of using the same in the treatment of hyperproliferative diseases.
摘要:
Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
摘要翻译:提供了结合ICAM-1的人源化抗体。 抗体包括选自:SEQ ID NO:1和3(HumA)的那些; SEQ ID NO:5和7(HumB); SEQ ID NO:9和11(HumC); SEQ ID NO:13和15(HumD); SEQ ID NO:17和19(HumE); SEQ ID NO:21和23(HumF); SEQ ID NO:25和27(HumG); SEQ ID NO:29和31(HumH); 和SEQ ID NO:33和35(HumI)。 还提供了能够结合ICAM-1表位的人源化抗体的子序列。 还提供了使用能够结合ICAM-1表位的人源化抗体抑制细胞病原体感染(例如HRV)的方法。
摘要:
Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting methods and conventional antibody therapy and immunodiagnosis are provided.
摘要:
Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.
摘要:
Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting methods and conventional antibody therapy and immunodiagnosis are provided.
摘要:
Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
摘要翻译:提供了结合ICAM-1的人源化抗体。 抗体包括选自:SEQ ID NO:1和3(HumA)的那些; SEQ ID NO:5和7(HumB); SEQ ID NO:9和11(HumC); SEQ ID NO:13和15(HumD); SEQ ID NO:17和19(HumE); SEQ ID NO:21和23(HumF); SEQ ID NO:25和27(HumG); SEQ ID NO:29和31(HumH); 和SEQ ID NO:33和35(HumI)。 还提供了能够结合ICAM-1表位的人源化抗体的子序列。 还提供了使用能够结合ICAM-1表位的人源化抗体抑制细胞病原体感染(例如HRV)的方法。
摘要:
Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.